METiS Enters Collaboration with Eli Lilly for Next-Generation Tissue-Specific LNP Delivery Technologies Pharmaceutical Executive
Eli Lilly Rises 4% While Foundayo Nears European Approval; Amgen and Novo Nordisk Edge Higher 24/7 Wall St.
HK-listed Metis TechBio, Eli Lilly strike drug-delivery deal worth up to $1.1 billion Reuters
Eli Lilly stock hits all-time high at 1293.11 USD Investing.com
Bristol Myers vs. Eli Lilly: Is BMY’s Deep Valuation Discount Hiding an Opportunity? Yahoo Finance
Forget Eli Lilly and Novo: This Biotech Could Be a Surprising Winner in the Weight Loss Market The Motley Fool
Lilly's EloraTZP (combination of eloralintide and tirzepatide) delivered greater weight loss and A1C reduction vs. tirzepatide 15 mg in adults with obesity and type 2 diabetes Eli Lilly
State Street Health Care SPDR (XLV) Buys $25 Million More Eli Lilly on Oct. 16 Yahoo Finance
Eli Lilly signs Abu Dhabi deal for local packaging of weight-loss medicines Arabian Business
Lilly breaks ground in Houston, one of ten U.S. manufacturing sites announced since 2020 PR Newswire
Zepbound linked to lower healthcare costs in adults over age 55 with obesity according to a real-world study Eli Lilly
Can Eli Lilly’s Growth Keep Justifying its Premium? Yahoo Finance
How Will Eli Lilly's GLP-1 Portfolio Sales Aid Upcoming Q3 Results? Yahoo Finance
Lilly reports second-quarter 2026 financial results, raises full-year guidance, and highlights continued growth and pipeline progress Eli Lilly
Eli Lilly (LLY) Stock Dips While Market Gains: Key Facts Yahoo Finance
ELI LILLY & COMPANY (LLYCL1.SN) stock price, news, quote and history Yahoo Finance UK
Eli Lilly lawsuit against weight-loss drug seller gets another shave Courthouse News
Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions Eli Lilly
FDA approves Lilly's Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type 2 diabetes Eli Lilly
Eli Lilly stock: Wells Fargo keeps USD 1,330.00 target for Eli Lilly stock ad-hoc-news.de
Lilly calls on online platforms, payment companies and regulators to shut down the illegal retatrutide black market PR Newswire
Lilly's Foundayo (orforglipron), the only oral GLP-1 taken without food or water restrictions, was associated with significant weight loss in women at every stage of menopause Eli Lilly
Eli Lilly Sues More Vendors Selling ‘Illicit’ Weight Loss Drugs Bloomberg Law News
Lilly announces three acquisitions to build infectious disease portfolio Eli Lilly
Lilly's triple agonist, retatrutide, demonstrated significant reductions in A1C and weight in first Phase 3 trial for treatment of type 2 diabetes Eli Lilly
Eli Lilly Just Announced Game-Changing News The Motley Fool
Why Eli Lilly (LLY) Stock Is Up Today Yahoo Finance
Eli Lilly owes Nektar $90 mln in drug collaboration dispute, US jury says Reuters
Lilly to present new data on Foundayo, retatrutide, and eloraTZP at EASD 2026, as it strives to change the course of cardiometabolic health PR Newswire
Lilly reports first-quarter 2026 financial results, raises full year guidance, and highlights momentum of new medicines Eli Lilly
Lilly commits additional $4.5 billion across Indiana manufacturing sites, opens first dedicated genetic medicine facility Eli Lilly
Eli Lilly Stock Raised Its Forecast, So Why Is The Market Shrugging? Yahoo Finance
/C O R R E C T I O N -- Eli Lilly and Company/ PR Newswire
Eli Lilly takes aim at illicit market for its experimental weight-loss drug CBS News
Eli Lilly and Company (LLY)’s Weight-Loss Pill Just Won Its First Race in Europe. Novo Nordisk A/S (NVO) Still Has a Head Start Yahoo Finance
Is Eli Lilly (LLY) Still the Undisputed Leader in the $150 Billion Obesity Drug Market? Yahoo Finance
Is Eli Lilly Stock Running out of Steam? Yahoo Finance
Eli Lilly cracks down on illicit weight loss drug trade with US lawsuits Pharmaceutical Technology
Why Eli Lilly Topped the Market Today Yahoo Finance
Eli Lilly Stock Jumps 2.6% as Investors Flee Expensive Tech Yahoo Finance